Advances in topiramate as prophylactic treatment for migraine

被引：12

作者：

Hu, Chuan ^{[1
]}

Zhang, Yixin ^{[1
]}

Tan, Ge ^{[1
]}

机构：

[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing 400016, Peoples R China

来源：

BRAIN AND BEHAVIOR | 2021年 / 11卷 / 10期

关键词：

migraine; prophylactic treatment; topiramate; DOUBLE-BLIND; PREVENTION; PLACEBO; SAFETY; PHARMACOLOGY; PREVALENCE; GUIDELINE; EFFICACY; CURRENTS; NEURONS;

D O I：

10.1002/brb3.2290

中图分类号：

B84 [心理学]; C [社会科学总论]; Q98 [人类学];

学科分类号：

03 ; 0303 ; 030303 ; 04 ; 0402 ;

摘要：

It is well-known that topiramate as a kind of antiepileptic drug has been proved effective for migraine prevention in North America and Europe. However, topiramate is still viewed as an off-label medication for migraine treatment in China, partly because of the limited evidence in Chinese patients. We summarize the effects of topiramate on the frequency, severity, quality-of-life, and adverse event among migraine patients, including children and adolescent in this review, so as to provide reference for Chinese doctors.

引用

页数：9

共 36 条

[1] Analysis of safety and tolerability data obtained from over 1,500 patients receiving topiramate for migraine prevention in controlled trials [J].

Adelman, James ;

Freitag, Fred G. ;

Lainez, Miguel ;

Shi, Yingqi ;

Ascher, Steven ;

Mao, Lian ;

Greenberg, Steven ;

Hulihan, Joseph .

PAIN MEDICINE, 2008, 9 (02) :175-185

[2] Topiramate for migraine prevention - A randomized controlled trial [J].

Brandes, JL ;

Saper, JR ;

Diamond, M ;

Couch, JR ;

Lewis, DW ;

Schmitt, J ;

Neto, W ;

Schwabe, S ;

Jacobs, D .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (08) :965-973

[3]

Chinese Medical Association Group, 2016, Chin J Pain Med, V22, P721

[4] Effects of topiramate on sustained repetitive firing and spontaneous recurrent seizure discharges in cultured hippocampal neurons [J].

DeLorenzo, RJ ;

Sombati, S ;

Coulter, DA .

EPILEPSIA, 2000, 41 :S40-S44

[5] Topiramate in migraine prophylaxis -: Results from a placebo-controlled trial with propranolol as an active control [J].

Diener, HC ;

Tfelt-Hansen, P ;

Dahlöf, C ;

Láinez, MJA ;

Sandrini, G ;

Wang, SJ ;

Neto, W ;

Vijapurkar, U ;

Doyle, A ;

Jacobs, D .

JOURNAL OF NEUROLOGY, 2004, 251 (08) :943-950

[6] Topiramate as an inhibitor of carbonic anhydrase isoenzymes [J].

Dodgson, SJ ;

Shank, RP ;

Maryanoff, BE .

EPILEPSIA, 2000, 41 :S35-S39

[7] The impact of topiramate on health-related quality of life indicators in chronic migraine [J].

Dodick, David W. ;

Silberstein, Stephen ;

Saper, Joel ;

Freitag, Fred G. ;

Cady, Roger K. ;

Rapoport, Alan M. ;

Mathew, Ninan T. ;

Hulihan, Joseph ;

Crivera, Concetta ;

Rupnow, Marcia F. T. ;

Mao, Lian ;

Finlayson, Gary ;

Greenberg, Steven J. .

HEADACHE, 2007, 47 (10) :1398-1408

[8] Migraine [J].

Dodick, David W. .

LANCET, 2018, 391 (10127) :1315-1330

[9] Repression of stimulated calcitonin gene-related peptide secretion by topiramate [J].

Durham, Paul L. ;

Niemann, Christine ;

Cady, Roger .

HEADACHE, 2006, 46 (08) :1291-1295

[10] EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force [J].

Evers, S. ;

Afra, J. ;

Frese, A. ;

Goadsby, P. J. ;

Linde, M. ;

May, A. ;

Sandor, P. S. .

EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (09) :968-981

← 1 2 3 4 →